ILThree professors at the Technion-Israel Institute of Technology have been awarded research grants by the Israel Cancer Research Fund (ICRF). Professor Irit Ben Aharon is researching the long-term effects of chemotherapy on children born to mothers undergoing treatment during pregnancy, noting that previous studies only tracked outcomes through childhood. Dr. Ido Livneh is investigating 'backup systems' that allow cancer cells to survive after initial treatment, aiming to understand why cancers often recur. Both researchers are affiliated with Rambam Health Care Campus and the Technion's medical faculty. The study highlights ongoing efforts to improve cancer treatment and understanding of long-term health impacts.
Bias read (Center): The article presents balanced reporting on scientific research funded by a national organization, focusing on medical advancements without overt ideological framing. It describes the work of researchers without taking sides or promoting specific political agendas. The emphasis is on scientific rigor
